glp 1 gip dual agonist GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabe | DMSO Frontiers | Clinical perspectives on

1 Introduction The gutbrain peptide, glucagon-like peptide-1 (GLP-1), is encoded by the proglucagon (PPG) gene, which is expressed in the intestines and pancreas [for a review, see Holst (2007)]

The presence of this side effect did not impact the drug's effectiveness, however

This has led to increasing scientific interest in incretin hormones and incretin interactions, and several compounds based on dual- and multi-agonists are now being investigated for the treatment of metabolic diseases

Lancet 398(10295):143155

These effects explain why medications targeting the GLP-1 pathway have proven effective for both type 2 diabetes management and weight loss

Semaglutide effects on cardiovascular outcomes in people with overweight or obesity (SELECT): outcomes by sex